Clinical Trials Browser

INDUSTRY × Immunotherapy, Adoptive × Plasma cell × Clear all

NCT03448978 2024-07-01

Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma

Phase 1 Terminated

Multiple Myeloma

NCT05521802 2023-03-24

A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Recruiting

Multiple Myeloma

NCT04097301 2022-01-19

Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma

Phase 1/2 Terminated

8 enrolled 13 charts

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, Myeloid, Acute

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Phase 1/2 Unknown

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms